enrofloxacin has been researched along with tulathromycin in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bade, DJ; Brodersen, B; Bryson, WL; Corley, L; Robb, EJ; Rogers, KC; Sturgess, K; Tucker, CM | 1 |
| Blondeau, BJ; Blondeau, JM; Blondeau, LD; Borsos, S; Hesje, CE | 1 |
| Berghaus, RD; Heins, BD; Nydam, DV; Overton, MW; Woolums, AR | 1 |
| Blondeau, JM; Hesje, CK; Shebelski, SD | 1 |
| Foster, DM; Martin, LG; Papich, MG | 1 |
| Berghaus, R; Credille, B; Crosby, S; Giguère, S | 1 |
| Blondeau, JM; Fitch, SD | 1 |
| Altier, C; Foditsch, C; Pereira, RVV; Siler, JD; Warnick, LD | 1 |
| Altier, C; Jordan, D; Mann, S; Pereira, RV; Siler, JD; Warnick, LD | 1 |
| Altier, C; Dulièpre, SC; Foditsch, C; Garzon, A; Pereira, RV; Siler, JD; Warnick, LD | 1 |
3 trial(s) available for enrofloxacin and tulathromycin
| Article | Year |
|---|---|
Efficacy of tulathromycin or enrofloxacin for initial treatment of naturally occurring bovine respiratory disease in feeder calves.
Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Bovine Respiratory Disease Complex; Cattle; Colorado; Disaccharides; Enrofloxacin; Fluoroquinolones; Heterocyclic Compounds; Injections, Subcutaneous; Recurrence; Texas; Treatment Outcome; Weight Gain | 2007 |
Comparative efficacy of enrofloxacin and tulathromycin for treatment of preweaning respiratory disease in dairy heifers.
Topics: Animals; Anti-Infective Agents; Bacterial Typing Techniques; Body Weight; Cattle; Disaccharides; Enrofloxacin; Female; Fluoroquinolones; Heterocyclic Compounds; Linear Models; Logistic Models; Respiratory Tract Diseases; Treatment Outcome; Weaning | 2014 |
Longitudinal effects of enrofloxacin or tulathromycin use in preweaned calves at high risk of bovine respiratory disease on the shedding of antimicrobial-resistant fecal Escherichia coli.
Topics: Animals; Anti-Bacterial Agents; Bovine Respiratory Disease Complex; Cattle; Cattle Diseases; Disaccharides; Enrofloxacin; Escherichia coli; Feces; Heterocyclic Compounds; Risk Assessment | 2020 |
7 other study(ies) available for enrofloxacin and tulathromycin
| Article | Year |
|---|---|
Comparative minimum inhibitory and mutant prevention drug concentrations of enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin against bovine clinical isolates of Mannheimia haemolytica.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cattle Diseases; Cephalosporins; Disaccharides; Drug Resistance, Multiple, Bacterial; Enrofloxacin; Fluoroquinolones; Heterocyclic Compounds; Mannheimia haemolytica; Microbial Sensitivity Tests; Thiamphenicol; Tylosin; United States | 2012 |
Bactericidal effects of various concentrations of enrofloxacin, florfenicol, tilmicosin phosphate, and tulathromycin on clinical isolates of Mannheimia haemolytica.
Topics: Animals; Anti-Bacterial Agents; Cattle; Disaccharides; Enrofloxacin; Fluoroquinolones; Heterocyclic Compounds; Mannheimia haemolytica; Microbial Sensitivity Tests; Pneumonia of Calves, Enzootic; Thiamphenicol; Tylosin; United States | 2015 |
Comparison of Active Drug Concentrations in the Pulmonary Epithelial Lining Fluid and Interstitial Fluid of Calves Injected with Enrofloxacin, Florfenicol, Ceftiofur, or Tulathromycin.
Topics: Animals; Anti-Bacterial Agents; Biological Availability; Cattle; Cephalosporins; Cross-Over Studies; Disaccharides; Enrofloxacin; Epithelial Cells; Extracellular Fluid; Fluoroquinolones; Heterocyclic Compounds; Lung; Male; Mannheimia haemolytica; Microbial Sensitivity Tests; Respiratory Mucosa; Thiamphenicol; Veterinary Drugs | 2016 |
Comparative efficacy of enrofloxacin to that of tulathromycin for the control of bovine respiratory disease and prevalence of antimicrobial resistance in Mannheimia haemolytica in calves at high risk of developing bovine respiratory disease.
Topics: Animals; Anti-Bacterial Agents; Bovine Respiratory Disease Complex; Cattle; Disaccharides; Double-Blind Method; Drug Resistance, Bacterial; Enrofloxacin; Fluoroquinolones; Georgia; Heterocyclic Compounds; Incidence; Male; Mannheimia haemolytica; Prevalence; Random Allocation | 2018 |
Mutant prevention and minimum inhibitory concentration drug values for enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin tested against swine pathogens Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis.
Topics: Actinobacillus pleuropneumoniae; Animal Husbandry; Animals; Anti-Bacterial Agents; Cephalosporins; Disaccharides; Drug Resistance, Multiple, Bacterial; Enrofloxacin; Heterocyclic Compounds; Microbial Sensitivity Tests; Pasteurella multocida; Streptococcus suis; Swine; Swine Diseases; Thiamphenicol; Tylosin | 2019 |
Effects of treatment with enrofloxacin or tulathromycin on fecal microbiota composition and genetic function of dairy calves.
Topics: Animals; Anti-Bacterial Agents; Cattle; Disaccharides; Drug Resistance, Microbial; Enrofloxacin; Feces; Heterocyclic Compounds; Microbiota; RNA, Ribosomal, 16S | 2019 |
Genotypic antimicrobial resistance characterization of E. coli from dairy calves at high risk of respiratory disease administered enrofloxacin or tulathromycin.
Topics: Animals; Anti-Bacterial Agents; Cattle; Disaccharides; Drug Resistance, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Feces; Genome, Bacterial; Genotype; Heterocyclic Compounds; Longitudinal Studies; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction; Prevalence; Sequence Analysis, DNA | 2020 |